Global Autoinjectors Market Is likely to Grow at a CAGR of 17.42% Over the Forecast Period 2019-2024


Market Overview:
The worldwide autoinjectors market has been projected to generate a worth of USD 79,741 million by 2024. The market is likely to grow at a CAGR of 17.42% over the forecast period.
An autoinjector is a medical equipment that is mostly used in delivering doses of certain drugs. The autoinjectors are syringes that come with spring loaded within it. These devices are simple to use and handle. Hence, autoinjectors have become widely popular among unskilled or untrained individuals. Autoinjectors are generally used for self-administration purposes. There has been a prevailing anxiety regarding self-administration with the application of needle-based devices. Therefore, autoinjectors came as an answer to such anxieties. The self-administration cure market shows tremendous growth potential particularly in the needle-free injectors and pen injectors segments, consequently impacting the autoinjector market positively.
The autoinjector technology has evolved largely in the recent times. The device comprises a pre-filled cartridge or syringe placed inside an equipment that puts sufficient force to inject fully the needed drug as per the required dosage.
Access Full Report Details and Full TOC Exclusively @ https://www.marketresearchfuture.com/reports/autoinjectors-market-6311
Key Players:
·         Amgen Inc
·         Dickinson and Company
·         Ypsomed
·         Teva Pharmaceutical Industries Ltd
·         SHL Group
·         Owen Mumford Ltd
·         Consort Medical
·         Eli Lilly and Company
·         Antares Pharma
·         Johnson & Johnson Services Inc
Market Segmentation:
The global autoinjectors market has been segmented based on the design therapeutic application, product type, region, and distribution channel.
Based on product type, the global autoinjectors market has been segmented into reusable autoinjectors and disposable autoinjectors. Disposable autoinjectors segment held a major market share during 2018. The segment has been anticipated to dominate the market and record a significant CAGR to attain USD 53,696.20 million by the conclusion of 2024. Growing demand for new drug testing, chemical testing, biopharmaceutical, and pharmaceutical drives the disposable autoinjectors segment to a large extent. Moreover, the disposable autoinjectors segment is likely to witness the highest CAGR of 17.90% over 2019 to 2024.
Regional Analysis:
In 2018, the Americas registered the highest market share of 40.6%, and the regional market has been anticipated to record a CAGR of 16.60% over the forecast period. By 2024, the European market has been anticipated to exceed USD 24,307.74 million by 2024. The technological progress, novelty in drug delivery framework, rising prevalence of anaphylaxis incidences, well-established healthcare infrastructure, cancer, and diabetes are the aspects affecting the rapid expansion of the global autoinjectors market in the area. Germany has been a key contributor to the development of the local market, trailed by France. The Asia-Pacific market has been likely to list the swiftest CAGR. The Indian market has been anticipated to reflect the largest growth rate of 18.95% over the forecast period of 2019 to 2024.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more